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Abstract
A variety of intercalating amphipaths increase the chemical activity of plasma membrane cholesterol. To test whether
intracellular cholesterol can be similarly activated, we examined NPC1 and NPC2 fibroblasts, since they accumulate large
amounts of cholesterol in their late endosomes and lysosomes (LE/L). We gauged the mobility of intracellular sterol from its
appearance at the surface of the intact cells, as determined by its susceptibility to cholesterol oxidase and its isotope
exchange with extracellular 2-(hydroxypropyl)-b-cyclodextrin-cholesterol. The entire cytoplasmic cholesterol pool in these
cells was mobile, exchanging with the plasma membrane with an apparent half-time of ,3–4 hours, ,4–5 times slower
than that for wild type human fibroblasts (half-time ,0.75 hours). The mobility of the intracellular cholesterol was increased
by the membrane-intercalating amphipaths chlorpromazine and 1-octanol. Chlorpromazine also promoted the net transfer
of LE/L cholesterol to serum and cyclodextrin. Surprisingly, the mobility of LE/L cholesterol was greatly stimulated by
treating intact NPC cells with glutaraldehyde or formaldehyde. Similar effects were seen with wild type fibroblasts in which
the LE/L cholesterol pool had been expanded using U18666A. We also showed that the cholesterol in the intracellular
membranes of fixed wild-type fibroblasts was mobile; it was rapidly oxidized by cholesterol oxidase and was rapidly
replenished by exogenous sterol. We conclude that a) the cholesterol in NPC cells can exit the LE/L (and the extensive
membranous inclusions therein) over a few hours; b) this mobility is stimulated by the activation of the cholesterol with
intercalating amphipaths; c) intracellular cholesterol is even more mobile in fixed cells; and d) amphipaths that activate
cholesterol might be useful in treating NPC disease.
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Introduction
This study concerns the mobility of intracellular cholesterol and,
in particular, its exit from late endosomal and lysosomal (LE/L)
compartments. The unesterified cholesterol in the cytoplasm of
most cells is scant. We have therefore examined Niemann-Pick C
(NPC) cells, because they bear large amounts of cholesterol (along
with certain membrane phospholipids) in multilamellar inclusions
within their LE/L [1,2]. This phenotype results from the lack of
functional NPC1 and/or NPC2 proteins. NPC2 is a water-soluble
cholesterol-binding protein located in the lumen of the LE/L
where it appears to shuttle sterol molecules from the membranous
inclusions therein to the NPC1 protein in the boundary
membranes [3–6]. NPC1 is a membrane-spanning, cholesterol-
binding protein that facilitates the exit of cholesterol from the
boundary membranes of the LE/L by an unknown mechanism
[3,4,7,8].
The phenotype of NPC disease strongly suggests that an NPC1/
NPC2 pathway provides the major route by which cholesterol
normally exits from the LE/L, and it is widely held that in
NPC1
2/2 cells ‘‘no known pathway exists for rapidly moving
sequestered lysosomal sterol to the plasma membrane’’ [9].
However, there is evidence that the surfeit of LE/L cholesterol
in NPC cells is not trapped there but, rather, turns over on a time
scale of hours [10–12]. These findings suggest the existence of a
second, normally minor route by which cholesterol can leave the
LE/L. This unknown pathway is probably critical for prolonging
NPC cell survival, so that the therapeutic enhancement of this
alternate route might help to alleviate the intracellular accumu-
lation of cholesterol in NPC disease. In fact, two recently reported
strategies have described such interventions. In one approach,
ingestion of the sterol-binding agent, HPCD, reduced the
intracellular cholesterol in cultured NPC1 cells as well as in
afflicted animals [8,9,13–17]. The other strategy was to increase
the level of acid sphingomyelinase in the LE/L of NPC1 cells; this
too mobilized the sequestered cholesterol by hydrolyzing sphin-
gomyelin, its high-affinity binding partner [18]. The exit pathway
for the mobilized LE/L cholesterol in these cases is unknown.
The present study sought to test the hypothesis that activators of
plasma membrane cholesterol also mobilize cytoplasmic choles-
terol. Active membrane cholesterol is that fraction not held in
complexes with polar lipids. The cholesterol in such lipid
complexes has a relatively low chemical activity, escape tendency
or fugacity [19,20]. In contrast, active cholesterol appears to have
an increased frequency and/or extent of projection into the
aqueous environment. In particular, the fraction of plasma
membrane cholesterol that exceeds the complexing capacity of
its polar lipid partners is more accessible to water-soluble probes
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excess plasma membrane cholesterol redistributes down its activity
gradient to the endoplasmic reticulum and mitochondria where it
elicits homeostatic responses [20,21].
Membrane-intercalating amphipaths competitively displace
sterols from their complexes with phospholipids and thereby
activate them [19,22–25]. We have now tested two such
amphipaths, 1-octanol and CPZ (chlorpromazine), for their ability
to mobilize the large pool of LE/L cholesterol in NPC1 and NPC2
cells. We found that CPZ promoted the net transfer of this
cholesterol to serum lipoproteins and that CPZ and octanol
accelerated LE/L cholesterol transfer to the plasma membrane.
Glutaraldehyde also has been observed to increase the activity of
membrane cholesterol [26–28]; we now show that it too mobilizes
the LE/L cholesterol in NPC1 cells. The surprising nature of some
of these results was explored in various control experiments; these
indicated that the observed mobilization of intracellular choles-
terol was not due to the disruption of cell integrity or permeability
barrier but rather to activation of the sterol.
Results
Effect of amphipaths on the net transfer of NPC cell
cholesterol to serum
Figure 1 shows that, as would be expected, the unesterified
cholesterol in untreated NPC cells did not change appreciably
during an overnight incubation with 10% fetal calf serum. In
contrast, the presence of CPZ caused a 30–60% decrease in
unesterified cholesterol in the two NPC1 and one NPC2 cell lines.
Parallel experiments showed that, at the end of the overnight
incubation, 21% of the total cholesterol in NPC1 line 93.59 was in
the ester form, compared to 12% in the untreated control. This
augmented esterification is in keeping with other evidence that
CPZ activates membrane cholesterol [22,25]; this increases the
cholesterol pool in the endoplasmic reticulum and thereby
stimulates cholesterol esterification [23,24]. We infer that the bulk
of the cholesterol lost from the cells had been transferred to the
serum acceptor; however, such increments could not be measured
accurately because of the high cholesterol content of the serum
lipoprotein sink.
The subcellular distribution of the unesterified cholesterol
remaining after the overnight incubation of NPC cells with serum
was estimated by analyzing the biphasic kinetics of the oxidation of
this cholesterol at the outer surface of cells after their fixation by
glutaraldehyde. (This technique, termed Method B, is fully
characterized below.) We see in Table 1 that CPZ stimulated far
more loss of cell surface and intracellular cholesterol than can be
accounted for by the increment in the esterified fraction
mentioned above. We infer that the missing cholesterol had been
transferred to the serum. That CPZ drove the redistribution of
plasma membrane and intracellular cholesterol to serum implies
that it raised the chemical activity of the sterol in the cells more
than that in the serum lipoproteins. We also found that the
addition of HPCD further enhanced the loss of cholesterol from
both the plasma membrane and the intracellular compartments of
the CPZ-treated cells (Table 1).
Exchange of [
3H]cholesterol between untreated
fibroblasts and extracellular cholesterol
We tested whether the stimulation of the transfer of intracellular
cholesterol to serum by CPZ resulted from cholesterol activation
by analyzing the kinetics of [
3H]cholesterol exchange between
uniformly-labeled cells and an ‘‘infinite’’ sink of unlabeled
extracellular cholesterol held in HPCD complexes (Method A).
First, we examined wild-type fibroblasts (Figure 2A). We found
that all of the cell [
3H]cholesterol became accessible at the cell
surface over time; hence, the intracellular fraction must have been
entirely mobile. Approximately 80% of the cell [
3H]cholesterol
could be assigned to the fast (plasma membrane) compartment
(Table 2), a fraction similar to that reported previously [11]. The
half-time for the exchange of the slow (intracellular) compartment
was ,0.75 h, a value concordant with diverse estimates of
intracellular cholesterol dynamics [20].
Three NPC cell lines were also examined using Method A
(Figure 2B–D). Cell cholesterol mass remained nearly constant
during these exchange incubations, suggesting chemical equilib-
rium, while .60% of the [
3H]cholesterol was transferred to (i.e.,
exchanged with) the acceptor. Extrapolations of the best fits of the
data to infinite time suggested that essentially all of the NPC1 and
NPC2 [
3H]cholesterol exchanged with the extracellular sink in
Figure 1. Effect of chlorpromazine on cholesterol transfer from NPC cells to serum. Cells in 6-well plates were grown to confluence in
DME10 (i.e., DME containing 10% fetal calf serum). Wells were then incubated at 37uC with 1 ml DME10 without (#) or with 20 mM chlorpromazine
(,). At the indicated times, duplicate pairs of wells were assayed for unesterified cell cholesterol and protein and the data averaged; the remaining
wells were given fresh medium and the incubation continued. Panel A, NPC1 line 93.59. Panel B, NPC1 line 93.41. Panel C, NPC2 line 99.04. Data for
each cell line were pooled from 2 or 3 experiments.
doi:10.1371/journal.pone.0030051.g001
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intracellular cholesterol was evident. The cholesterol content of
the plasma membrane of the NPC cells was roughly comparable to
that of wild-type fibroblasts (Table 2). The half-time for its exit to
the acceptor was 5–10 min, similar to that found for normal cells
in these experiments (Table 2). In contrast, the tK for the
exchange of the slow (intracellular) cholesterol compartment in the
NPC cells was ,2.5–4 h, several times slower than the wild-type.
These values are similar to those previously reported for NPC1
cells [10,11]. The cholesterol content of the slowly-exchanging
cholesterol pools in the three NPC cell lines was about ten times
greater than in the wild-type, so that the intracellular pools
amounted to two-thirds or more of the total cell cholesterol. These
findings are consistent with numerous earlier studies demonstrat-
ing that the excess cholesterol in NPC fibroblasts resides in their
LE/L; see, for example, [1,11,14,29,30]. We therefore take the
slowly exchanging pool in the NPC cells to represent their LE/L
cholesterol.
Effect of amphipaths on the exchange of [
3H]cholesterol
between fibroblasts and extracellular cholesterol
Treating NPC1 fibroblasts with either of the two amphipaths
accelerated the slow exchange step in Method A (Figure 2B–D and
Table 2). The half-times of the slow process in line 93.59 were
reduced about 3- and 6-fold by octanol and CPZ, respectively, so
that they then resembled the values for the wild-type. For NPC1
line 93.41 and NPC2 line 99.04, the half-time for the slow step was
decreased by the two agents by about 25%.
Kinetics of cholesterol exchange in glutaraldehyde-
treated NPC fibroblasts
While glutaraldehyde has been shown to activate membrane
cholesterol [26–28], we were nevertheless surprised to find that
virtually all of intracellular [
3H]cholesterol in the three lines of
NPC cells exchanged with the extracellular HPCD-cholesterol sink
after fixation with glutaraldehyde (Figure 3 and Table 3).
Furthermore, glutaraldehyde fixation accelerated the slow step
(i.e., the movement of LE/L cholesterol to the cell surface) by 3- or
4-fold in the NPC1 cells and by ,1.7-fold in the NPC2 cells.
Glutaraldehyde did not significantly stimulate the already rapid
rate of exchange of the plasma membrane [
3H]cholesterol pool.
Treating glutaraldehyde-fixed NPC1 or NPC2 fibroblasts with
either of the two intercalating amphipaths, octanol and CPZ,
caused little further acceleration of the already rapid exchange of
the LE/L cholesterol (Table 3).
Kinetics of the oxidation of cholesterol in fixed NPC
fibroblasts
A second measure of the mobility of intracellular cholesterol is
the rate of its oxidation by cholesterol oxidase at the cell surface
(Method B). Figure 4A shows that the time-course of cholesterol
oxidase attack on the cholesterol mass in fixed wild-type fibroblasts
was biphasic and that the entire cellular pool was accessible at the
cell surface, just as in the case of [
3H]cholesterol exchange with
extracellular HPCD-cholesterol in unfixed cells (Figure 2A). Both
the fast and slow processes varied in proportion to the
concentration of cholesterol oxidase (not shown). 82% of the
cholesterol in the wild-type fibroblasts was attributable to the
plasma membrane (Table 4), a value similar to that found for
unfixed fibroblasts (Figure 2 and Table 2) and in an earlier study
[11].
Fixed NPC1 and NPC2 fibroblasts also gave biphasic time
courses of oxidation (Figure 4B–D). The half-times of oxidation of
the slow pools in the fixed NPC cells (Table 4) were generally
similar to those obtained for [
3H]cholesterol exchange (Table 3)
and significantly greater than those seen in unfixed cells (Table 2).
The addition of either CPZ or octanol to the fixed cells further
mobilized the slow compartment in the two NPC1 lines but not in
NPC2 cells.
Increasing the glutaraldehyde concentration from 1% to 4%
and raising the temperature of fixation of the NPC1 cells from 0uC
to 37uC further enhanced both the fast and slow rate processes in
subsequent tests (not shown). The effects of the glutaraldehyde
treatments were mimicked by 4% formaldehyde; however,
100 mM acetaldehyde had no effect on the oxidation of cell
cholesterol by cholesterol oxidase (not shown).
Net transfer of cholesterol from fixed cells to extracellular
HPCD
Figure 5 shows that the initial rate of transfer of cholesterol mass
from glutaraldehyde-fixed cells to extracellular cyclodextrin was
significantly stimulated by CPZ in all three cell lines. In particular,
Table 1. Effect of chlorpromazine on cholesterol exit from
NPC fibroblasts to serum.
Cells Line % Serum CPZ HPCD cells PM IC
mg cholesterol/mg cell
protein
NPC1 93.59 20 2 82.7 36.7 46.0
+ 60.4 25.7 34.7
(0.73) (0.70) (0.75)
93.59 10 2 75.3 25.5 59.3
+ 59.8 24.0 34.6
(0.79) (1.0) (0.66)
93.59 10 2 96.9 35.6 61.4
++ 53.2 21.5 31.7
(0.55) (0.60) (0.52)
93.59 10 2 122.8 44.1 78.9
++ 68.2 24.5 43.5
(0.56) (0.55) (0.55)
NPC1 93.41 20 2 117.2 28.4 88.8
+ 86.0 25.1 60.9
(0.73) (0.88) (0.68)
93.41 10 2 92.9 33.6 59.3
+ 74.1 29.0 45.0
(0.80) (0.86) (0.76)
NPC2 99.04 10 2 95.7 36.4 59.3
+ 78.8 23.7 55.1
(0.82) (0.65) (0.93)
99.04 10 2 87.8 43.6 44.2
+ 59.2 26.1 33.1
(0.67) (0.60) (0.75)
In multiple replicate experiments, duplicate 75 cm
2 flasks were incubated at
37uC with 10 ml DME containing 10 or 20% fetal calf serum with or without
20 mM chlorpromazine and 0.15% (i.e., ,1 mM) HPCD. The medium was
replenished after 3, 7 and 21 h of incubation as depicted in Figure 1. After 24 h,
the distribution of cholesterol between the plasma membrane (PM) and
intracellular (IC) pools was determined by fixing the cells and analyzing the time
course of their reaction with cholesterol oxidase as described for Method B in
Materials and Methods. The parenthetic values represent fractional changes; i.e.,
quotients of (plus CPZ)/(minus CPZ).
doi:10.1371/journal.pone.0030051.t001
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from the three NPC cell lines during a 1-hour incubation.
(Fixation inactivates cholesterol esterification, ruling out this
activity as a cause of the loss of cell cholesterol. Furthermore,
cholesterol depletion was dependent on the presence of HPCD.)
From Table 1, we know that no more than one-third of the
cholesterol in these NPC cells resides in the plasma membrane;
also, the preponderance of the intracellular cholesterol is in the
LE/L [1,11,14,29,30]. Since, presumably, not all of the plasma
membrane cholesterol in the CPZ-treated cells was removed
during the incubation, a large fraction of the cholesterol
transferred to the HPCD must have come from the LE/L.
Visualizing cholesterol mobility in fibroblasts fixed with
formaldehyde
To independently confirm the high mobility of intracellular
cholesterol in fixed cells, we used the cholesterol-specific
fluorescent probe, filipin, to follow cholesterol dynamics after
formaldehyde treatment. (Glutaraldehyde gave a high autofluo-
rescence background in such experiments; fortunately, as men-
tioned earlier, formaldehyde also mobilized cholesterol.) As widely
observed, filipin weakly stained the plasma membrane as well as
numerous round cytoplasmic vesicles in the fixed wild-type
fibroblasts (Figure 6A). As is typical of LE/L in these cells, the
stained vesicles clustered near the nuclei and sometimes capped
them irregularly; e.g., see [30,31]. A 10 min incubation of these
fibroblasts with cholesterol oxidase abolished nearly all of the
filipin staining (Figure 6B). That the cholesterol oxidase treatment
did not perturb the cytoarchitecture but simply removed most of
the sterol is made clear by Figure 6C; here, viewing the same field
as in panel B at high image intensity revealed that normal cell
morphology was preserved.
For Figure 6D, cells that had been fixed and then cleared with
cholesterol oxidase as in panel B were replenished by incubating
Figure 2. Effect of chlorpromazine on cell [
3H]cholesterol exchange with cholesterol-cyclodextrin: Method A. These representative
experiments were carried out and analyzed as described in Materials and Methods. Panel A, wild-type fibroblasts. Data were fit to a first-order
expression (dashed line, R
2=0.975, t1/2=7 min) as well as to a second-order expression (solid line, R
2=0.998). The latter fit suggests that 21% of the
cholesterol was intracellular and that the values for the half-times of the fast and slow processes were 5 min and 44 min. Panel B, NPC1 cell line 93.59.
(#), Minus CPZ: 61% of the cholesterol was intracellular and the t1/2 values were 7 min and 288 min. (,), Plus 50 mM CPZ: 71% of the cholesterol was
intracellular and the t1/2 values were 8 and 47 min. Panel C, NPC1 line 93.41. (#), Minus CPZ: 71% of the cholesterol was intracellular and the t1/2
values were 11 and 222 min. (,), Plus 50 mM CPZ: 79% of the cholesterol was intracellular and the t1/2 values were 6 and 138 min. Panel D, NPC2 line
99.04. (#), Minus CPZ: 64% of the cholesterol was intracellular and the t1/2 values were 8 and 117 min. (,), Plus 50 mM CPZ. 59% of the cholesterol
was intracellular and the t1/2 values were 7 and 115 min.
doi:10.1371/journal.pone.0030051.g002
Table 2. Dynamics of intracellular [
3H]cholesterol in wild-type and NPC cells.
Cell type Line Treatment
Plasma membrane
cholesterol
Intracellular
cholesterol Half-time, min
mg/mg cell protein Fast step Slow step
Wild-type None 23.7636 . 5 60.6 5.360.5 4762
NPC1 93.59 None 31.567 70.0696 . 9 60.4 237651
0.8 mM Octanol 4.960.8 85615
0.05 mM CPZ 3.7624 1 62
NPC1 93.41 None 25.063 75.0636 . 5 60.5 162624
0.8 mM Octanol 10.0651 2 9 630
0.05 mM CPZ 5.0611 3 0 68
NPC2 99.04 None 39.166 61.0668 . 4 611 5 7 627
0.05 mM CPZ 6.3611 1 9 621
The distribution and kinetics of exchange of [
3H]cholesterol from monolayers of fibroblasts to an HPCD-cholesterol sink were determined and analyzed as described for
Method A in Materials and Methods and illustrated in Figure 2. Stated values are means 6 average deviations for 2 experiments except for the untreated line 99.04 for
which a SD for 5 determinations is given; the average of the nine average deviations was 615% as was the one standard deviation determined.
doi:10.1371/journal.pone.0030051.t002
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regained the normal staining pattern of the plasma membrane and
intracellular vesicles, except that they were generally brighter than
untreated controls. We infer that cholesterol can move within
minutes and in both directions between the cell surface and well-
preserved intracellular membrane compartments in fixed wild-
type fibroblasts as well as in NPC cells.
Control experiments
Could the increase in intracellular cholesterol accessibility caused
by amphipaths have reflected cell disruption? Countering this
hypothesis, we note that cholesterol mass was not lost from the NPC
cells during the exit of most of the cellular [
3H]cholesterol to
cyclodextrin. Furthermore, we observed that NPC fibroblasts
incubated with amphipaths and the cyclodextrin-cholesterol ex-
change partner had a normal appearance by phase contrast
microscopy. Similarly, CPZ had no visible effect on the number,
size or intensity of staining of the fluorescent endocytic compart-
ments in unfixed wild-type and NPC1fibroblasts that had previously
ingested fluorescently-labeled dextran (Figure 7). We also found that
the effectof CPZon themobilization of LE/Lcholesterolwasmostly
reversed by washing out the agent prior to assay (not shown). While
cyclodextrin has been shown to promote LE/L sterol excretion by
causing lysosome exocytosis [32], we observed only a small release of
b-galactosidase,an LE/Lacidhydrolase, from the NPC fibroblasts –
and this was not increased by octanol or CPZ (not shown). Finally,
Figure 3. Effect of glutaraldehyde on NPC fibroblast cholesterol dynamics: Method A. Representative experiments showing the exchange
of [
3H]cholesterol between homogeneously-labeled glutaraldehyde-fixed cells and HPCD-cholesterol, as described in Materials and Methods. Panel A,
NPC1 cell line 93.59. (#), Unfixed cells: 76% of the cholesterol was intracellular and the t1/2 values were 6 and 186 min for the fast and slow
compartments. (D), Fixed cells: 69% of the cholesterol was intracellular and the t1/2 values were 3.7 and 44 min. Panel B, NPC1 cell line 93.41. (#),
Unfixed cells: 78% of the cholesterol was intracellular and the t1/2 values were 6 and 186 min. (D), Fixed cells: 69% of the cholesterol was intracellular
and the t1/2 values were 15 and 59 min. Panel C, NPC2 cell line 99.04. (#), Unfixed cells: 68% of the cholesterol was intracellular and the t1/2 values
were 7.5 and 187 min. (D), Fixed cells: 74% of the cholesterol was intracellular and the t1/2 values were 6 and 105 min.
doi:10.1371/journal.pone.0030051.g003
Table 3. Effect of glutaraldehyde on [
3H]cholesterol dynamics in fixed fibroblasts.
Cells Line Amphipath Fixation % intracellular Half-time, min
Fast step Slow step n
Wild-type * - 2 21.5615 . 3 60.5 47623
NPC1 93.59* - 2 70696 . 9 60.4 237651 2
- + 61677 . 9 645 3 692
0.8 mM Octanol + 81694 . 4 60.3 46652
0.05 mM CPZ + 66655 . 5 60.2 35642
NPC1 93.41* - 2 7563.0 6.560.5 162624 2
- + 68.560.5 9.065.0 52672
0.8 mM Octanol + 85.564.5 3.460.6 51.560.5 2
0.05 mM CPZ + 78673 . 7 624 1 622
NPC2 99.04* - 2 61668 . 4 61 157627 5
- + 64616 . 3 60.9 119621 3
Cells were pre-equilibrated with [
3H]cholesterol, fixed or not while still in culture flasks and the exchange of label with an HPCD-cholesterol sink determined and
analyzed as described for Method A in Materials and Methods and illustrated in Figure 3. Values for duplicate experiments are means 6 average deviations; for n.2,
values are means 6 S.D.
*Data for untreated control cells were taken from Table 2.
doi:10.1371/journal.pone.0030051.t003
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ingestionand transferto theLE/L[15],the rapidexitofintracellular
[
3H]cholesterol to extracellular cyclodextrin was not blocked (but
rather stimulated) in glutaraldehyde-fixed cells in which the
endocytosis of HPCD should not occur.
It was also relevant to assess whether CPZ might have caused
cholesterol to accumulate in the LE/L. CPZ is one of many
amphipathic amines that induce phospholipidosis; that is, the
accumulation of large amounts of polar (glyco- and phospho-)
lipids in the LE/L of wild-type cells [33,34]. Some agents in this
category also appear to cause cholesterol to build up in the LE/L;
for example, see [35]. However, we could not find strong evidence
in the literature that CPZ actually causes an increase in
intracellular cholesterol. In fact, upon examination, we found that
CPZ did not alter the content of unesterified cholesterol in wild-
type human fibroblasts over 2 days (Figure 8). In contrast,
U18666A (a prototypic lysosomotropic tertiary amine) promoted
massive sterol accumulation, as has been widely reported [36–38].
We also considered the possibility that fixation with glutaral-
dehyde and formaldehyde mobilized membrane cholesterol by
disrupting or permeabilizing the cells. However, we observed that
fixed cells retained their morphological integrity (Figure 6).
Furthermore, fixation did not increase the shedding of cytoplasmic
proteins but rather prevented their release, even from cells lysed
with Triton X-100 (Figure 9). Finally, Live/Dead analyses showed
that only a small fraction of NPC1 cells that were fixed with either
glutaraldehyde or formaldehyde allowed calcein to exit or
ethidium to enter the cell interior (Figure 10).
We also obtained indirect evidence that the mobilization of
intracellular cholesterol by fixation in fact reflects its activation. For
this, we treated fixed cells with a lysophosphatide because such
membrane-intercalating agents associate with and thereby reduce
the activity of membrane cholesterol [20,23–25]. As shown in
Figure 11,lysophosphatidylserine strongly inhibitedthe oxidationof
cholesterol in glutaraldehyde-fixed NPC1 cells. (Accelerating time
courses for the action of cholesterol oxidase on membrane
cholesterol such as that seen in Figure 11 have been observed
previously [26]. This effect may be related to the stimulation of the
reaction by the reaction product, cholest-4-en-3-one (cholestenone),
presumably through the displacement of substrate cholesterol from
its association with membrane phospholipids and its consequent
activation [39].) Note that cholesterol oxidase should not be able to
access the LE/L in fixed cells, even if their plasma membranes were
leaky; thus, the mechanism of action of the aldehydes is likely to be
through cholesterol activation and mobilization.
[A cautionary note: That glutaraldehyde fixation does not
inhibit but actually increases the flux of intracellular cholesterol to
the cell surface can account for high estimates previously reported
for the fraction of cell cholesterol associated with the plasma
membrane; namely, up to 94% in fixed wild-type fibroblasts [40].
That is, the fixation used in those analyses presumably promoted
the circulation of intracellular cholesterol to the cell surface during
prolonged incubations with cholesterol oxidase. Thus, the high
mobility of intracellular cholesterol, even in fixed cells, can
complicate the analysis of its in situ distribution and dynamics.
Unfortunately we know of no general inhibitor of intracellular
cholesterol movement other than cold temperature.]
Figure 4. Effect of amphipaths on cholesterol dynamics in fixed fibroblasts: Method B. Representative experiments depicting the action
of cholesterol oxidase on glutaraldehyde-treated cells as described in Materials and Methods. Panel A, wild-type fibroblasts. Fits were to a single
(dashed line) and a two-exponential expression (solid line). In the two-exponential fit, 18% of cholesterol was intracellular and the t1/2 values were 2
and 21 min for the fast and slow compartments. Panel B, effect of CPZ on NPC1 cell line 93.59. (#), Minus CPZ: 61% of the cholesterol was
intracellular and the t1/2 values were 3.6 and 35 min. (D), Plus 50 mM CPZ: 65% of the cholesterol was intracellular and the t1/2 values were 0.5 and
12 min. Panel C, effect of octanol on NPC1 cell line 93.41. (#), Minus octanol: 61% of the cholesterol was intracellular and the t1/2 values were 2.7 and
35 min. (D), Plus 0.8 mM octanol: 64% of the cholesterol was intracellular and the t1/2 values were 0.4 and 3.5 min. Panel D, effect of CPZ on NPC2 cell
line 99.04. (#), Minus CPZ and (D) plus 50 mM CPZ were both fitted by the same parameters: 60% of the cholesterol was intracellular and the t1/2
values were 1 and 8 min.
doi:10.1371/journal.pone.0030051.g004
Table 4. Effect of amphipaths on cholesterol dynamics in
fixed fibroblasts.
Cells Line Treatment
%
intracellular Half-time, min
Fast step Slow step n
Wild-type None 18632 . 2 60.7 23643
NPC1 93.59 None 63611 2.0612 4 610 6
Octanol 6766 0.2060.03 5.060.4 2
CPZ 60620 . 4 60.1 9.3622
NPC1 93.41 None 59633 . 0 614 0 684
Octanol 63614 0.4960.08 5.662.5 4
NPC2 99.04 None 5662 0.9560.05 12622
CPZ 58611 . 0 60.2 1060.5 2
Cells were suspended, fixed, washed and preincubated for ,5 min at 37uC with
0.05 mM CPZ or 0.8 mM octanol. Cholesterol oxidase was then added to initiate
time courses which were analyzed as described in Method B of Materials and
Methods and illustrated in Figure 4. Values are means 6 average deviations for
2 independent experiments or means 6 SD for n.2.
doi:10.1371/journal.pone.0030051.t004
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The transport of cholesterol molecules among cellular mem-
brane compartments, including the LE/L, normally proceeds with
time constants on the order of tens of minutes or less, apparently
mediated by a variety of transfer proteins [7,20,41–43]. Despite
the absence of a functional NPC1/NPC2 pathway, the large
cholesterol pool in the LE/L of NPC fibroblasts is also mobile,
Figure 5. Effect of chlorpromazine on net cholesterol transfer from fixed NPC cells to cyclodextrin. Cells were dissociated, washed,
incubated with 1% glutaraldehyde for 30 min on ice, washed again and resuspended in PBS. Aliquots of 100 ml (containing,100 mg protein) were
placed in tubes and made to 0 (O) or 40 mM chlorpromazine (=). After a 10 min pre-incubation at 37uC, HPCD was added to a concentration of 5%
(,36 mM) to each tube and the incubation continued. At the times indicated, pairs of tubes were chilled, the cells washed and unesterified
cholesterol determined. The input (not exposed to CPZ or HPCD) defined the initial cholesterol. Panel A, NPC line 93.59. Panel B, NPC1 line 93.41.
Panel C, NPC2 line 99.04. Shown are representatives of several similar experiments.
doi:10.1371/journal.pone.0030051.g005
Figure 6. Dynamics of intracellular cholesterol visualized by filipin staining. Wild-type fibroblasts were grown on Falcon culture slides,
rinsed with PBS (pH 7.4), fixed with 4% formaldehyde in PBS for 30 min on ice, rinsed and incubated with or without cholesterol oxidase. Staining
with filipin III (10 mg/ml PBS) was at room temperature for 30 min in the dark. Images were obtained using an Olympus IX81 microscope and
analyzed with Image J software. There was no detectable fluorescence in the absence of filipin. Panel A, formaldehyde-fixed control fibroblasts. Panel
B, as in Panel A, except that the cells were treated after fixation with 0.6 U/ml cholesterol oxidase for 10 min at 37uC. Panel C, same field as Panel B
but shown at a high intensity setting. Panel D, cells were fixed and treated with cholesterol oxidase as in Panel B, then washed and replenished by
incubation in PBS containing 1.1 mg/ml cyclodextrin bearing 30 mg/ml cholesterol in PBS for 10 min at 37uC, then rinsed before staining.
doi:10.1371/journal.pone.0030051.g006
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few hours; see Results and [10,11]. Other evidence for the
mobility of LE/L cholesterol in NPC1 cells is that these
compartments can be emptied simply by growing the cells without
serum lipoproteins for a few days; see, for example, [44].
We now report that CPZ and 1-octanol increased the mobility
of LE/L cholesterol in both NPC1 and NPC2 fibroblasts. The
actions of these amphipaths were uniformly strong in one cell line
(NPC1 93.59), moderate in another (NPC1 93.41) and variable in
a third (NPC2 99.04); these differences are consistent with the
significant variations seen in the phenotypes of NPC individuals
[45,46]. It seems likely that amphipaths mobilize NPC LE/L
cholesterol by displacing it from strong associations with the
bilayer lipids, thereby enhancing its chemical activity (see
Introduction). This mechanism can explain why sphingomyelin,
which binds cholesterol avidly, inhibits the ability of NPC2 to
catalyze the removal of the sterol from bilayers while ceramides,
which displace cholesterol competitively from its association with
phospholipids [25], stimulate this process [47]. The ability of 25-
hydroxycholesterol to increase the egress of cholesterol from the
LE/L of NPC1 cells [11,48] presumably also reflects amphipath-
mediated activation [49,50], given that this oxysterol also
promotes the reactivity of cholesterol with cholesterol oxidase as
well as its transfer to b-cyclodextrin and to the endoplasmic
reticulum [24,51,52].
Figure 7. Morphological integrity of cells treated with chlorpromazine. Wild-type (panels A and B) and NPC1 line 93.59 cells (panels C and
D) growing on cover slips in wells containing DME10 were fed FITC-Dextran (3 mg/ml) for 3 h at 37uC. 20 mM chlorpromazine was then added to two
wells (panels B and D) and all were incubated for an additional hour at 37uC. The cells were fixed on ice for 30 min with 1% glutaraldehyde in PBS
(pH 8); autoflorescence was quenched with 20 mM glycine in PBS for 5 min at 37uC and the cells rinsed and examined in a Zeiss Axiovert 100
fluorescence microscope.
doi:10.1371/journal.pone.0030051.g007
Figure 8. Effect of chlorpromazine and U18666A on cell
cholesterol accumulation. Replicate flasks of wild-type fibroblasts
were incubated in DME10 containing no additions (#), 20 mM CPZ (%)
or 5 mM U18666A (,). At the times indicated, cells were dissociated
with trypsin, washed and assayed in duplicate for unesterified
cholesterol and protein. Data from two experiments were pooled.
doi:10.1371/journal.pone.0030051.g008
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of cell cholesterol can be grouped in three classes. The term class 1
amphipaths has been used to designate agents that mimic the
effect of excess cell cholesterol [53]; it appears that this effect often
reflects their ability to displace membrane cholesterol from
phospholipid complexes and thereby to activate it. Class 1
includes octanol, CPZ, 25-hydroxycholesterol and dozens of other
amphipaths [19,22,25,49,50]. Class 2 amphipaths such as
U18666A appear to sequester sterol in the LE/L and thereby
reduce plasma membrane cholesterol [11,36–38,53]. A third
group of intercalators, which we shall call class 3 amphipaths,
reduce the activity of bilayer cholesterol, apparently by forming
complexes with it. Class 3 includes phospholipids, lysophospha-
tides and hexadecylphosphocholine [19,20,26,54].
CPZ has sometimes been considered to be a class 2 agent
because of its potential to induce LE/L lamellar body formation or
‘‘lipidosis’’ [33,34]. However, it does not fit well into this category
[34]. In particular, CPZ does not cause cholesterol accumulation
in wild-type human fibroblasts as do typical class 2 agents
(Figure 8). Rather, it behaves as a class I (cholesterol-activating)
amphipath; see Results and [25]. The ability of CPZ to stimulate
SCAP may also reflect this ability [55,56]. In contrast, the
prototypic class 2 agent, U18666A, stimulates the accumulation of
LE/L cholesterol (e.g., Figure 8 and [11,36–38,53]) but does not
increase cholesterol esterification [57], promote SCAP activation
[56] or activate red cell or fibroblast cholesterol (not shown). We
therefore infer that CPZ is a strong class I agent and, at best, a
weak class 2 agent, while the reverse is the case for U18666A.
To our surprise, glutaraldehyde and formaldehyde did not block
the accessibility of intracellular cholesterol to cyclodextrin
(Figure 3) or cholesterol oxidase (Figure 4) but, in fact, stimulated
it. Since aldehydes do not chemically modify sterols or bilayer
lipids other than aminophospholipids (see p. 33 in [58]), their
action here would seem to be indirect.
We suggest that the mechanism involves activation of LE/L
cholesterol [26,27,28]. This premise is supported by the reversal of
the glutaraldehyde effect by the cholesterol-complexing interca-
lator, lysophosphatidylserine (Figure 11). Furthermore, we found
that the transfer to HPCD of both plasma membrane and
intracellular [
3H]cholesterol in fixed NPC cells was associated with
a high energy of activation, ,25 Kcal/mole (not shown). These
high activation energies are comparable to those observed with
unfixed cell membranes and bilayer vesicles [59], suggesting that
glutaraldehyde-stimulated efflux faces the same hydrophobic
barrier (namely, cholesterol hydration) as obtains in normal
bilayers.
How cholesterol traverses the fixed cytoplasm in an accelerated
fashion is mysterious, given that cytosolic shuttle proteins should
be immobilized by glutaraldehyde. However, even in fixed cells,
cholesterol could diffuse along bilayers to the protein-based
junctions that bridge apposed organelle membranes; downhill
transfer could then occur at these sites [7,41,43,60,61]. Alterna-
tively, cytoplasm fixed by glutaraldehyde is permeable to small
molecules; see, for example, the experiment with calcein AM
shown in Fig. 10C; also ref. [62]. It is therefore conceivable that
sterols are transported by small aqueous shuttles; however,
evidence for such carriers is lacking. A case can be made for the
unmediated desorption of sterol molecules from bilayers followed
by their aqueous diffusion to acceptors [63,64]. But the
characteristic time for such transfers is usually a few hours; in
one study, the unaided exit of cholesterol from washed lysosomes
took days [65]. Still, the desorption of active membrane cholesterol
might be more rapid. Finally, we note that the collisional transfer
of membrane cholesterol, at least to b-cyclodextrin, can proceed
with a tK of seconds or less [59] and is stimulated both by
amphipaths and by glutaraldehyde, presumably through its
activation [11,20,23–25]. Thus, collisional transfers between
closely-spaced donors and acceptors in fixed cells might still occur
on a time-scale of several minutes.
In conclusion, we have demonstrated that, in fibroblasts lacking
functional NPC1 or NPC2 proteins, cholesterol exits the surface
and lumenal membranes of the LE/L by an alternate route. This
pathway (or pathways) is stimulated when cholesterol is activated
both by cross-linking with aldehydes and by membrane-permeable
Figure 9. Release of proteins from cells fixed by aldehydes. NPC1 cells were grown to confluence in 6-well plates, the monolayers rinsed and
then incubated for 1 h on ice with 0.4 ml PBS with or without 1% glutaraldehyde (glut, panel A) or 4% formaldehyde (form, panel B). The wells were
then rinsed and incubated for 20 min at 37uC with PBS with or without 0.1% TX-100. The contents of input wells were harvested in 0.1% in Triton X-
100 plus 0.1 N. NaOH. To measure protein release in the other wells, the overlying medium in wells incubated with or without 0.1% Triton X-100 was
collected and saved, and the adherent residues harvested in 0.1 N. NaOH. Before assay, all samples were adjusted with concentrates to 0.1% Triton X-
100 and 0.1 N. NaOH, then treated with 5% trichloroacetic acid and spun. The precipitates were washed once with 5% trichloroacetic acid, dissolved
in 0.1 N. NaOH and the protein assayed. Summing the media and pellets indicated full recovery of the input protein. Values are averages of duplicate
determinations on duplicate wells 6 average deviation in a representative experiment.
doi:10.1371/journal.pone.0030051.g009
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reagent for the study of intracellular cholesterol transport, the
effects reported here nevertheless constrain our thinking about this
process. In addition, our findings suggest that drugs that activate
LE/L cholesterol stores might offer a useful adjunct in treating
NPC disease. In particular, exogenous acid sphingomyelinase
releases LE/L cholesterol from its high-affinity binding partner
[18,47] and presumably activates it thereby, as is seen with other
sphingomyelinases [66,67]. Acid sphingomyelinase therapy might
therefore be potentiated by well-chosen sterol-activating (class 1)
amphipaths. The mobilization of sequestered LE/L cholesterol by
b-cyclodextrins [8,9,13–16] might similarly be enhanced by class 1
amphipaths, given that these agents stimulate the net transfer of
intracellular cholesterol to HPCD; see Figure 5 and [23,24].
Scores of amphipaths of different types activate membrane
cholesterol [25]. Thus, selected drugs like CPZ (ThorazineH) that
cross the blood-brain barrier and, being lysosomotropic, accumu-
late in acidic LE/L compartments might prove to have value in
the treatment of NPC disease.
Materials and Methods
Materials
Cholesterol, 1-octanol, CPZ, cholesterol oxidase (Streptomyces sp),
filipin III, HPCD (ave. MW=1396) and glutaraldehyde were
purchased from Sigma-Aldrich. 1a,2a-[
3H]cholesterol was from
American Radiolabeled Chemicals or Perkin Elmer. U18666A
was obtained from Biomol and lysophosphatidylserine from
Avanti. The Live/Dead assay kit was from Invitrogen.
Cell culture and treatments
Normal human foreskin fibroblasts were cultured to ,90%
confluence in DME10; 75 cm
2 flasks contained ,2 mg protein
and ,70 mg cholesterol at ,3561 mg (SEM, n=24) cholesterol/
mg protein. The two lines of heterozygous human skin fibroblasts
lacking detectable NPC1 protein were obtained from Peter
Pentchev. The mutations in the heterozygous NPC1 line 93.59
are 275A.G and 395delC (Walter D. Park, personal communi-
cation); these alterations create missense and frame shift errors that
Figure 10. Permeability of fixed NPC1 cells: Live/Dead assay.
Cells of NPC1 line 93.59 were grown on glass cover slips, rinsed and
treated as described below. They were then incubated with 3 mM
calcein AM plus 5 mM ethidium D homodimer for 30 min at room
temperature, rinsed and inverted onto glass slides for fluorescence
microscopy using a Zeiss Axiovert 100 microscope. Left column, calcein
fluorescence; right column, ethidium fluorescence. Row A: untreated
fibroblasts. Row B: Cells were incubated with 3.2% formaldehyde in PBS
for 30 min on ice, quenched with 50 mM NH4Cl for 10 min at room
temperature and rinsed. Row C: Cells were incubated with1%
glutaraldehyde in PBS for 30 min on ice, quenched with 20 mM glycine
in PBS for 10 min at room temperature and rinsed. Row D: Cells were
incubated in growth medium containing 20 mM CPZ for 1 h, then rinsed
and stained. Row E: Cells were incubated with glutaraldehyde as in
panel C, then washed and incubated with 0.1% Triton X-100 in PBS for
15 min at room temperature, rinsed and stained.
doi:10.1371/journal.pone.0030051.g010
Figure 11. Effect of lysophosphatidylserine on cholesterol
dynamics in fixed NPC1 fibroblasts. Cells of NPC line 93.59 were
suspended, fixed, washed, resuspended to 1.2 mg protein in 0.5 ml PBS
(pH 6.6) and incubated for 5 min at 37uC without (#) or with (D)
lysophosphatidylserine (150 mM; ,0.8 mol/mol cholesterol). The time
course of cholesterol oxidase action was then analyzed as described for
Method B in Materials and Methods. The half-times for the fast and slow
steps in the cells lacking lysophosphatidylserine were estimated to be
2.5 and 36 minutes, with 39% of the cholesterol in the fast
compartment and 61% in the slow compartment. One of two similar
experiments is shown.
doi:10.1371/journal.pone.0030051.g011
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line 93.59 had 8664 (SEM, n=16) mg cholesterol/mg protein.
The mutations in the NPC1 line 93.41 are 2926T.C and
3265G.A (Walter D. Park, personal communication); these create
missense and splicing errors with a severe biochemical phenotype
[45,46]. Our cultures of line 93.41 had 11267 (SEM, n=13) mg
cholesterol/mg protein. The NPC2 cells were NIH line 99.04;
these cells are homozygous for a G58T substitution that produces
an E20X stop codon that blocks NPC2 protein expression and
creates a severe biochemical phenotype [46]. These NPC2 cells
had 8262 (SEM, n=10) mg cholesterol/mg protein. All cells were
cultivated in DME10 and were mechanically dissociated following
a 1 min incubation at 37uC in PBS (pH 8.0) containing 0.05%
trypsin and 0.02% EDTA, as described [68]. The cells were
washed and, unless stated otherwise, kept on ice in PBS (pH 7.4).
CPZ was introduced in PBS (pH 7.4), while non-polar compounds
were in ethanol (#1% final).
Magnitude and dynamics of intracellular cholesterol
determined by [
3H]cholesterol exchange (Method A)
As described previously [11], cells in 75 cm
2 flasks were pulse-
labeled with ,1 mCi of [
3H]cholesterol and allowed to equilibrate
over 1 day of culture (.6 half-times of exchange between cell
surface and intracellular compartments). The cells were rinsed,
dissociated and re-plated in DME10 in 25 cm
2 flasks; this step
eliminated contamination by stray [
3H]cholesterol stuck to the
labeled growth flasks. After re-attachment for 3 h, the monolayers
were rinsed, incubated in PBS (pH 8.0) with or without 1%
glutaraldehyde for 20–30 min on ice, rinsed and preincubated
with 1 ml PBS (pH 7.4) with or without amphipaths for 5 min at
37uC. This incubation medium was collected for the zero-time
point. The flasks were then incubated at 37uC in 1 ml fresh PBS
(pH 7.4) with or without amphipaths containing this exchange
partner: 38 mg cholesterol carried in 25–28 mg HPCD. (This
cocktail was developed empirically so that the cell sterol mass
remained nearly constant during the exchange of the [
3H]choles-
terol.) To obtain data points, the overlying medium was harvested
and replenished several times during the incubation; this
procedure made the exit of [
3H]cholesterol quasi-irreversible.
The supernatant media were cleared by centrifugation and their
radioactivity determined. Residual cell radioactivity, cholesterol
mass and protein were determined at the end of the time courses.
Protein was analyzed in duplicate by BCA (Pierce kit) using a BSA
standard; cholesterol was determined by HPLC [68]. Cell
attachment and integrity were monitored by phase contrast
microscopy during all incubations.
Determination of the magnitude and dynamics of the
intracellular cholesterol compartment by cholesterol
oxidase susceptibility at the cell surface (Method B)
Cells were grown to confluence, dissociated from their flasks,
washed and aliquots taken for the determination of cholesterol and
protein. The remainder was incubated for 20 min on ice with 1%
glutaraldehyde in PBS (pH 8.0), washed, resuspended to ,1m g
protein/ml PBS (pH 6.6) and amphipaths added. The samples
were preincubated at 37uC for ,5 min and time courses then
initiated by the addition of cholesterol oxidase to 40 IU/ml. [A
high level of cholesterol oxidase was used to accentuate the
difference between the oxidation of the cell surface (fast) and
intracellular (slow) pools.] At intervals, aliquots were extracted for
the analysis by HPLC of the mass of the remaining cholesterol and
the cholest-4-en-3-one (cholestenone) product [68].
Analysis of kinetic data
The time courses for cell [
3H]cholesterol exchange (Method A)
and for the interaction of cell cholesterol with cholesterol oxidase
(Method B) were clearly not first-order butconformed well to the bi-
exponential expression, y=ae
2bt+ce
2dt (see, for example, Figs. 2, 3
and 4). Least-squares best fits were obtained after assigning an
infinitetimepoint whichwas93–102%oftransfer oroxidation. Best
fits to this equation all had R
2 values greater than 0.99. We took the
coefficients a and c in the expression to represent the sizes of the cell
surface and intracellular cholesterol compartments, respectively.
The apparent first order rate constants, b and d, yielded values for
the half-times of the fast and slow processes respectively; that is,
tK=ln 2/b and tK=ln 2/d.
Because the half-times for the reaction of the intracellular pool
are complex functions of its movement between the cell surface
and intracellular compartments plus the unidirectional exit or
oxidation step, true rate constants for transfer to and from the LE/
L cannot be extracted from the data; see page 15 in [69]. The
actual rate constants for the exit of cholesterol from the LE/L
presumably exceeded the values suggested by the observed half-
times because the inward flux of plasma membrane cholesterol will
replenish the LE/L and thereby slow its clearance from that space.
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